A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice

SARS-CoV in 2003, SARS-CoV-2 in 2019, and SARS-CoV-2 variants of concern (VOC) can cause deadly infections, underlining the importance of developing broadly effective countermeasures against Group 2B Sarbecoviruses, which could be key in the rapid prevention and mitigation of future zoonotic events....

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, David R., Schaefer, Alexandra, Gobeil, Sophie, Li, Dapeng, De la Cruz, Gabriela, Parks, Robert, Lu, Xiaozhi, Barr, Maggie, Manne, Kartik, Mansouri, Katayoun, Edwards, Robert J., Yount, Boyd, Anasti, Kara, Montgomery, Stephanie A., Shen, Shaunna, Zhou, Tongqing, Kwong, Peter D., Graham, Barney S., Mascola, John R., Montefiori, David. C., Alam, Munir, Sempowski, Gregory D., Wiehe, Kevin, Saunders, Kevin O., Acharya, Priyamvada, Haynes, Barton F., Baric, Ralph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095197/
https://www.ncbi.nlm.nih.gov/pubmed/33948590
http://dx.doi.org/10.1101/2021.04.27.441655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095197/
https://www.ncbi.nlm.nih.gov/pubmed/33948590
http://dx.doi.org/10.1101/2021.04.27.441655

Ejemplares similares